Campaign Against HCV

Question: Discuss about the Report of "Campaign Against HCV" . Answer: TASK WHO WAS RESPONSIBLE? PREDICTED VS ACTUAL COMPLETION ESTIMATED VS ACTUAL COST IF TIME OR COST GREATER THAT ESTIMATED- EXPLAIN Screening and diagnosing for HCV virus in the general population Dr. Stephane ( A local GP) December 2016 (Predicted) VS December 2016 (Actual) Predicted; $ 200, 000 Actual; $220, 000 We realized that we needed to purchase more screening facilities that we had estimated. Increased knowledge to obstetrics-gynecology specialists. Dr. Vincent Lockwood (Health awareness officer) Dr. Ann Griffin (Nurse) December 2016 (Predicted) VS June 2016 (Actual) Predicted; $ 50, 000 Actual; $80, 000 We had to hire more trainers to teach the gynecology specialists and physician on the prevention of HCV transmission than we had earlier predicted. Boost in the knowledge about the HCV epidemic Miss Gilbert ( Disease control officer) June 2015 (Predicted) VS December 2015 (Actual) Predicted; $120, 000 Actual; $150, 000 We had to hire more specialist to go interact with people and teach them and still employ specialists in hospitals. More time required to reach remote areas. Increased institutional capacity on the response of HCV ailments among the injective drug users. Dr. Harvey (International GP) March 2015 (Predicted) VS June 2015 (Actual) Predicted; $100, 000 Actual; $120, 000 We hired more trainers as the institutions in the city have increased than we had earlier estimated. More time was used to get to all institutions. Increased access to justifiably and feasibility of routine HCV screening among pregnant women. Dr. Mc Queen December 2016 (Predicted) VS June 2017 (Actual) Predicted; $80, 000 Actual; $120, 000 After hearing of free screening, pregnant women came in large numbers hence increase in cost and time. Modernization of the safety procedures used by doctors Dr. Alaric Saltzman December 2016 (Predicted) VS June 2017 (Actual) Predicted; $ 70, 000 Actual; $ 100, 000 We had to increase trainers to teach medical staff on the safety methods to practice to prevent the spread of the disease. More time for training was used than estimated. Improvement of techniques used for monitoring and sanitary control. Miss. Caroline June 2016 (Predicted) VS June 2016 (Actual) Predicted; $50, 000 Actual; $80, 000 We bought new incinerators for institutions. Improved the prevention measure of the HCV infection Mrs. June Madete Senior Biomedical Engineer December 2015 (Predicted) VS June 2016 (Actual) Predicted; $100, 000 Actual; $ 120, 000 We hired more trainers in the field that we had earlier estimated. Specialist trainers required more time for training sessions. Increased awareness to the public. Mr. Rick Spectra March 2015 (Predicted) VS December 2015 (Actual) Predicted; $100, 000 Actual; $110, 000 We hired more trainers in the field that we had earlier estimated However, we had t increase the number of months due to huge ignorance of the disease counteracted the social stigmatization of people with HCV disease Miss. Sarah Redpath June 2015 (Predicted) VS June 2015 (Actual) Predicted; $50, 000 Actual; $50, 000 There was no difference as people received the message as we expected the inclusion of the injective drug users in the prevention programs of the HCV disease Dr. Jon Snow December 2016 (Predicted) VS June 2017 (Actual) Predicted; $80, 000 Actual; $ 50, 000 The injective drug users proved cooperative than we had earlier estimated. 24 months predicted by December 2016 Late by six months A total of $ 1 million. An overspent by $200, 000 The kind of information to collect I would first collect the information on how the disease is caused and how it enters our bodies. Like the method of its spreading. I would also collect information on how the disease affects our body how they lead to the inflammation of the liver (Adinolfi, Gambardella, Andreana, Tripodi, Utili, Ruggiero, 2001). I would also collect data on how the disease affect the general functioning of the body and the early symptoms of the disease. Information on how the medication provided for the disease how the work in our bodies is also crucial. I would also collect the information regarding the awareness of the disease to the general public and deduce if they are aware of their health status if they go for a regular screening or not. I would also collect information on the number of the infected people with the disease around Yarra City. Information regarding the percentages of the transmission of the disease would also prove value as it will help me analyze which is the primary way in whi ch the disease is spread. Information regarding how early the disease can be diagnosed and treatment availability (Alberti, Morsica, Chemello, Cavalletto, Noventa, Pontisso, Ruol, 1992). What kinds of data do you need to evaluate the ten tasks? For the screening and diagnostics of the HCV viruses in the general population I will need data on how well equipped are or medical institutions to deal with the diagnostics and treatment of the disease. I will also require data on the total number of medical officers who specialize in the screening process. I would also require data on the total population screened and those found with the disease and those found without so as to calculate the percentage ratio of the disease infection in Yarra City (Bacon, Gordon, Lawitz, Marcellin, Vierling, Zeuzem, Burroughs, 2011). With the increased knowledge on obstetrics-gynecology to prevent HCV infection, I would require data on how many female populations visit the health centers to be screened for the disease. The determine the total population of those who are found with the disease and compare them wth those who dont have it and come up with a ratio of this. With the boast of knowledge about HCV epidemic, I will need data on which part of Yarra City has been s prominent with the disease and the locals are ignorant of it and its methods of transmission. I will also need knowledge of which is the best form of communication that will be certain that my information has been received by nearly all if not all (Martell, Esteban, Quer, Genesca, Weiner, Esteban, Gomez, 1992). Wth the increase institutional capacity on response to HCV, I will need data on which government and private institution are prominent with the disease. I will also need data on which institution are doing absolutely nothing to combat the disease (Ward,2012). Increased accessibility to justifiable HCV screening I will need data on the percentage of transmission from mother to child. I would also need data on how many pregnant women have the disease and measures the government has put in place to ensure children born of infected mothers are not exposed to the disease (Thornbory, 2004). Data requirements for modification and modernization of safety procedure by medical staff will include the percentage of disease infection through this technique especially when the medical officer is administering an injection since it is the most prominent mode of transmission of HCV virus (Jadoul, 1996). Data gathering My organization will be responsible for the data collection. This will take place as I will form a group aimed at extensive data collection. Yes, they will accept the data collected by the research group I have formed because am going to employ the qualitative and quantitative data collection method. This is so because the qualitative approach will deal with the why, the disease is still claiming more and more lives around, it will also deal with the aspect of why measures put forward by the ministry of health was not effective. It will also deal with the how the disease is being spread from one person to the next. And how the disease can be controlled (Mohd Hanafiah, Groeger, Flaxman, Wiersma, 2013). Yarra City HCV disease prevention project succeeded or failed? Why? The Yarra City HCV disease prevention control has failed. This is because from the data we collected there was a high level of ignorance level about the disease in Yarra City. Most of them knew about the disease but had no clue of the methods of transmission, the symptom of the disease, the difference between the acute and chronic type of the disease, pregnant mothers had no idea they can transmit the disease to their children, health workers didnt carry out proper sterilization before delivering an injection. There was also the issue of poor medical facilities installed in medical institutions to fight the disease. The Yarra City HCV control did not carry out campaign to sensitize the masses about illness and provide screening facilities to the population. All this points to a fail in that department (Marcellin, Roux, Winnock, Lions, Dabis, Salmon-Ceron, Carrieri, 2014). Communication of the findings First and foremost my project is aimed at sensitizing the masses of the disease, and priority is to create awareness with the statistical data collected about the disease. I will also provide information on which means was determined to be leading regarding the disease spreading in the area and offer the best medical care solution to them (US Public Health Service. 2001). Secondly, I will inform the ministry of health through the Yarra City HCV disease prevention so that together we can formulate policies on how to combat the disease. I would suggest we begin by creating awareness of the disease, how the disease is transmitted, the effects of the disease on somes health, prevention of contraction techniques and offer medical care to those infected (Intramuscular, 1998). References Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M. F., Utili, R., Ruggiero, G. (2001). Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology, 33(6), 1358-1364. Alberti, A., Morsica, G., Chemello, L., Cavalletto, D., Noventa, F., Pontisso, P., Ruol, A. (1992). Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. The Lancet, 340(8821), 697-698. Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., ... Burroughs, M. (2011). Boceprevir for previously treated chronic HCV genotype 1 infection. New England Journal of Medicine, 364(13), 1207-1217. Intramuscular, I. M. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Jadoul, M. (1996). Transmission routes of HCV infection in dialysis. Nephrology Dialysis Transplantation, 11(supp4), 36-38. Marcellin, F., Roux, P., Winnock, M., Lions, C., Dabis, F., Salmon-Ceron, D., ... Carrieri, M. P. (2014). Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Expert review of gastroenterology Hepatology, 8(4), 351-358. Martell, M., Esteban, J. I., Quer, J., Genesca, J., Weiner, A., Esteban, R., ... Gomez, J. (1992). Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of virology, 66(5), 3225-3229. Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., Wiersma, S. T. (2013). Global epidemiology of hepatitis C virus infection: New estimates of ageà ¢Ã¢â€š ¬Ã‚ specific antibody to HCV seroprevalence. Hepatology, 57(4), 1333-1342. Thornbory, G. (2004). Fighting blood-borne viruses. Occupational Health, 56(3), 22. US Public Health Service. (2001). Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control, 50(RR-11), 1. Ward, J. W. (2012). The hidden epidemic of hepatitis C virus infection in the United States: occult transmission and burden of disease. Topics in antiviral medicine, 21(1), 15-19.